HR4605Referred to Committee

End Prescription Drug Ads Now Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-22
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Jerrold Nadler
Jerrold Nadler
Democrat · NY · Representative
Votes with party: 98.6% (584 recorded votes)

Full profile: /officials/N000002

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

3 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-07-22

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The proposal would ban pharmaceutical companies from advertising prescription drugs directly to consumers on television, radio, and online platforms. Currently, drug makers spend billions of dollars on ads encouraging people to ask their doctors about specific medications, but this bill would eliminate that advertising while still allowing ads for over-the-counter drugs and medical devices. The change would primarily affect pharmaceutical companies' marketing budgets and could reduce the number of medication requests patients bring to their doctors' appointments.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.